AlphAIAlphAI — Financial news for AI agents
SEC EDGARJUN 41 min read$ATI

Fields Kimberly A sold $343K of ATI

Fields Kimberly A (Chair, President and CEO) sold 1,896 shares of ATI INC (ATI) at $180.80 ($0.34M total) on 2026-06-02 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Fields Kimberly A
Published Jun 4, 2026, 11:14 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 4, 2026, 11:16 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
About AlphAI AI DeskScoring methodologyReport an issue
AlphAI market briefInsider activity
Primary signal
$ATI
Neutral
medium confidence
Mentioned
$ATI
Relevance
6/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$ATINeutralLow
01

Why it matters

Insider selling can influence short-term sentiment, but 10b5-1 plans are designed to pre-schedule trades and typically dampen interpretive value.

02

Market read

A concrete insider sale datapoint for ATI, but with reduced bearish inference due to the 10b5-1 plan.

03

What to watch

Traders may over-weight insider selling; without context on total insider activity, option exercises, or subsequent filings, the standalone signal is weak.

Relevance 6/10Novelty 6/10Timing: Filed after-hours on 2026-06-04; sale occurred 2026-06-02.

Background

The article is an SEC Form 4 insider transaction disclosure for ATI, reporting an open-market sale by the CEO/Chair under a pre-arranged 10b5-1 plan.

Company-level read

Ticker impact

$ATINeutralMedium confidence
Context

ATI CEO/Chair Kimberly A. Fields sold 1,896 shares in an open-market transaction at $180.80 on 2026-06-02, disclosed via Form 4.

Expected impact

Low near-term impact; any reaction is likely limited unless accompanied by unusual volume or additional disclosures.

Evidence & confidence

Form 4 provides a specific sale datapoint, but the filing notes a pre-arranged 10b5-1 plan, which typically reduces signal strength versus discretionary selling.

Market effects

Sector

Minimal—single-company insider transaction with no stated operational/regulatory trigger.

Regional

None.

Global

None.

Counterpoint

What could challenge this read

If the 10b5-1 plan is part of routine liquidity management, the sale may be noise rather than a bearish read-through.

Key entities

  • issuer
    ATI INC

    Subject of the Form 4 insider sale by CEO/Chair Kimberly A. Fields.

  • insider
    Kimberly A. Fields

    Chair, President and CEO who sold 1,896 shares at $180.80.

Read at source← All news

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

ATI insider trading history →

Related articles

SEP 17
$ATIMed

How Investors Are Reacting To ATI (ATI) Record Backlog And Raised Guidance

ATI Inc. raised its 2026 adjusted EBITDA and free cash flow guidance, citing record backlog and strong aerospace and defense demand. The company's updated outlook includes high teens defense growth, reinforcing its long-cycle thesis. ATI's share price is up 64% year-to-date, outpacing its industry group. Key risks include execution challenges and softer demand in industrial and medical sectors.

simplywall.st2 min
SEP 15
$ATIMed

ATI Shares Surge 64% YTD: What's Driving the Momentum?

ATI Inc. shares have surged 64% year to date, outperforming the aerospace-defense industry and S&P 500. The company reports strong aerospace and defense demand, a record backlog, and improved profitability. Q2 2026 jet-engine revenue rose 13%, defense sales increased 36% to $162M, and adjusted EBITDA grew 37% to $284.4M. ATI raised its 2026 adjusted EBITDA outlook to $1.135-$1.185B and adjusted free cash flow guidance to $550-$600M.

tradingview.com2 min
SEP 11
$ATIMed

4 Top Aerospace & Defense Stocks to Consider as America Commemorates 9/11

Four aerospace and defense stocks (ATI, DCO, IA, LOAR) are highlighted as Strong Buys by Zacks, with strong Q2 earnings and raised guidance. ATI reported $1.26B in sales (+10% YoY), record backlog of $4.4B, and raised 2026 EPS guidance. DCO saw record revenue of $224.5M (+11% YoY) and adjusted EPS of $1.18 (+34% YoY). IA reported $26.7M in sales (+11% YoY) and doubled adjusted EPS to $0.33. LOAR posted $171.6M in sales (+39% YoY) and raised 2026 EPS outlook.

finance.yahoo.com3 min
SEP 5
$ATIMed

Extended Strategic Agreements to Support Management’s Full-Year 2026 Guidance Raise for ATI Inc. (ATI)

ATI Inc. (NYSE:ATI) raised its 2026 guidance after Q2 revenue rose 11% YoY to $1.26B, with adjusted EBITDA at $284.4M. The company secured long-term supply deals with BWX Technologies and Boeing, supporting its bullish outlook. However, risks include customer concentration and raw material cost volatility. Analysts remain bullish, with a consensus target price of $255.

yahoo.com3 min
SEP 2
$ATIMedAI 9/10

ATI’s (ATI) Record Backlog And Raised Guidance Signal Bigger Ambitions

ATI Inc. (NYSE:ATI) reported Q2 sales of $1.26B, up 11% YoY, with net income rising 50% to $151M. The company raised its full-year 2026 outlook, citing strong demand in aerospace and defense. ATI's backlog reached a record $4.4B, up 18% YoY. CEO Kimberly Fields noted demand outpacing supply, and the company repurchased $50M in shares. However, margins in one segment slipped, and debt increased to fund growth.

insidermonkey.com3 min
AUG 25
$ATIMed

Here's How Much a $1000 Investment in ATI Made 10 Years Ago Would Be Worth Today

ATI Inc., a Pittsburgh-based specialty materials producer, restructured in 2013 and 2020, focusing on High-Performance Materials & Components and Advanced Alloys & Solutions. In Q1 2026, earnings beat estimates but revenues missed. The company benefits from aerospace and defense demand but faces risks from production ramps and supply-chain issues.

qz.com3 min